Citigroup Reiterates Neutral Rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP)

Citigroup analysts reiterated a Neutral rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ:BRKRP) on January 16, 2026.

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A operates in the Healthcare sector. The stock currently trades at $377.59 with a market capitalization of $54,390,718,065.